PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2190785
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2190785
The Diagnostic Ultrasound Market reached USD 8.50 billion in 2025 and is projected to grow at a 4.7% CAGR from 2026 to 2035. The market is expected to cross USD 13.46 billion valuation by 2035. Real-time anatomical and functional imaging without ionizing radiation supports use across abdominal, obstetric, cardiac, vascular, and musculoskeletal care. Demand increasingly spans centralized departments and distributed clinical settings, making portability, automated workflows, and transducer capabilities important to equipment selection alongside image quality. The purchasing opportunity includes both established hospital systems and imaging closer to patients.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $8.50 Billion |
| Forecast Value | $13.46 Billion |
| CAGR | 4.7% |
Population aging, chronic disease, and AI-assisted acquisition drive demand. Older patients often require repeated cardiac, renal, vascular, and abdominal examinations, supporting continuing scan activity across care pathways. Cardiovascular, metabolic, hepatic, and renal disease management likewise creates sustained needs for diagnosis and surveillance. Providers consequently value equipment that produces consistent images across specialties and supports substantial procedure volumes. AI guidance and automated measurements make acquisition and documentation more repeatable for clinicians outside specialist sonography teams. These capabilities expand opportunities in emergency medicine, primary care, maternity services, and rural settings. Commercial demand extends to equipment, software upgrades, and a wider community of clinicians using imaging during routine patient care.
Across technology, 2D ultrasound accounted for 35.0% of revenue in 2025. Its broad clinical usefulness and familiar workflows support ongoing procurement in general imaging, obstetrics, and primary care. A lower entry cost preserves its relevance for providers that need established diagnostic capability within constrained budgets. Advanced imaging alternatives are gaining importance, but conventional equipment continues to address extensive routine requirements. The category's position depends on meeting those everyday clinical needs efficiently and reliably. Buyers can prioritize familiar operating procedures and accessible equipment while reserving higher-specification systems for applications that require additional visualization capability, preserving an important role for 2D imaging in varied care environments.
Considering portability, trolley/cart-based systems held 72.0% of revenue in 2025. High-acuity departments need extensive transducer options, advanced imaging functions, and integration with established clinical practices. These requirements support continued use of substantial departmental equipment even as handheld systems expand into decentralized care. Procurement therefore reflects the work a system must perform and the environment in which it will operate. Cart-based platforms remain relevant where clinicians need broad diagnostic functionality within established hospital workflows. Their commercial position rests on supporting demanding examinations and multiple applications, giving providers equipment capable of serving complex departmental requirements rather than only narrowly defined point-of-care tasks.
The Asia Pacific diagnostic ultrasound market is projected to generate USD 4.73 billion by 2035. High-income replacement demand and opportunities for new installations coexist, requiring suppliers to offer differing combinations of clinical performance and affordability. Local service and training are important to converting equipment purchases into usable imaging capacity. China's expanding healthcare infrastructure supports demand across price levels, while domestic manufacturing contributes production scale. Competitive local suppliers increase pressure in mid-tier equipment and encourage adoption of AI-assisted functions. Manufacturers serving the region need to balance premium capabilities with purchasing conditions and the practical support necessary for providers to operate systems consistently across a range of clinical settings.
GE Healthcare held over 27% market share in 2025. Its offerings cover premium cardiology and women's health, general imaging, and handheld equipment, giving it access to different clinical purchasing needs. Investment in clinical AI supports workflow automation and differentiated imaging performance. This positioning connects hardware capabilities with the efficiency of examination processes and the range of users able to acquire images. The breadth of the portfolio allows participation in established specialist departments and more distributed care. Its competitive approach therefore combines application-specific imaging with technology that helps providers manage acquisition and clinical workflows across different equipment formats and service environments.
Some of the major players in this market are Philips, Siemens Healthineers, Mindray, and Samsung Medison. Philips emphasizes echocardiography, decision support, connectivity, and health-system relationships. Siemens Healthineers addresses premium hospital imaging and interoperability, while Mindray competes through broad coverage, pricing, distribution, and AI capabilities. Samsung Medison focuses on women's health and fetal imaging. Across these suppliers, image quality, transducer choice, software-enabled workflows, and service coverage influence procurement as ultrasound expands into a wider range of clinical environments.